Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Researchers from University of Texas, Center for Biodefense and Emerging Infectious Diseases describe findings in vaccines
November 12th, 2008
Research findings, 'Chimeric alphavirus vaccine candidates for chikungunya,' are discussed in a new report. "Chikungunya virus (CHIKV) is an emerging alphavirus that has caused major epidemics in India and islands off the east coast of Africa since 2005. Importations into Europe and the Americas, including one that led to epidemic transmission in Italy during 2007, underscore the risk of endemic establishment elsewhere," scientists in the United States report. "Because there is no licensed human vaccine, and an attenuated Investigational New Drug product developed by the U.S. Army causes mild arthritis in some vaccinees, we developed chimeric alphavirus vaccine...
Source: Vaccine Weekly (2008-11-12)
|
